Bridge Neurotech is building a fully non-invasive, wearable brain-computer interface that reads brain activity through the skull using functional ultrasound imaging (fUSI) and AI-based neural decoding, removing the need for surgery or implants. Founded in 2026 in Silicon Valley by CEO Will Biederman, who developed the neural interface chip Neuralink used in its first devices and co-founded the nonprofit Forest Neurotech, the company is enrolling its first human research study in Redwood City, California. It licenses Butterfly Network's Ultrasound-on-Chip technology under a multi-year Butterfly Embedded agreement and targets applications across neurological care, communication, human-computer interaction and consumer use.
1
Round
1
Industry
5
Tags
Oct 6, 2026
Latest raise
Funding activity · 1 round
Oct 6, 2026
$13.5M
Seed
Led by General Catalyst
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
